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Thirty-eight patients aged 1 to 20 years (mean 11.2) were evaluated 
because of recurrent ventricular tachycardia. Thei follow-up period ranged 
from 0.5 to 12 years (mean 6). The patients were separated into two 
groups according to the presence or absence of known structural heart 
disease. Seventeen of the 21 patients with known heart disease were 
symptomatic (cardiac arrest in 5, syncope in 5, dizziness in 7) compared 
with only 6 of the 17 patients without heart disease (syncope In 3 and 
dizziness in 3) (p <O.Ol). All symptomatid patients had ventricular 
tachycardia with rat& of more than 150 beats/mln, whereas all but one 
of the asymptomatlc patients had rates of less than 150 beats/mln (p 
<O.Ol). Graded treadmill exercise testing was performed in 21 of the 36 
patient&. Exerclse,lncreased the degree of ventricular arrhythmia in 6 of 
the 11 symptomatic patients but decreaised or abolished the arrhyihmia 
in 9 of the 10 asymptomatlc patients (p <O&l). 
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Antiarrhythmlc therapy was used In 26 of the 36 patients. Effectiveness 
of therapy was assessed wlth both 24 hour Holter monitorlng and graded 
treadmill exercise testing. Therapy effectively abolished ventricular 
tachycardla and gieatly decreased the number of premature ventricular 
complexes in the symptomatic patients but was less effective in the 
asymptomatic patients. Thus, this study suggests that the presence of 
underlying heart disease, the rate of ventricular tachycardia and the results 
of graded treadmill exercise tests are Important in predicting the prognosis 
of children with ventricular tachycardia. 
Vetltricular tachycardia, unrelated to metabolic disorders, drugs or 
anesthesig or occurring during procedures such as surgery and cardiac 
catheterization, is rare in infants and children.l-9 Recent advances in 
ambulatory electrocardiographic recording& and invasive electrophys- 
iologic studies have increased our knowledge about ventricular ar- 
rhythmias in children, but little is known about the long-term course 
of these patients.’ In this report we review our experiences with ven- 
tricular tachycardia and assess the factors that are important in deter- 
mining the prognosis of children with this arrhythmia. 
Methods 
Patients: The diagnostic files of the vepartments of Pediatric Cardiology 
and Cardiovascular Surgery at the C. S. Moit Children’s Hospital, University 
of Michigan and the Department of Cardiology at the Walter Reed Army Medical 
Center were searched and the records of 38 children who had ventricular 
tachycardia were obtained and reviewed. In each patient, a,complete history, 
physical examination, serial electrocardiogram, 24 hour Holter electrocardio- 
grams, M mode echocardiograms and chest X-ray films were available. Labo- 
ratory tests in all 38 patients also included a complete blood count, urinalysis 
and deterinination of serum electrolytes including sodium, potassium, calcium 
and phosphorus, blood gases and serum thyroxine. Giaded treadmill exercise 
testing using the Bruce protocollo was performed in 21 patients and cardiac 
catheterization in 24. The diagnosis of ventricular tachycardia was made using 
standard scaler electrocardiographic criteria of a successioti of three or more 
ventricular extrasystoles with atrioventricular dissociation and fusion and 
capture QkS complexes.’ 
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Electrophysiologic studies: Seven patients underwent 
electrophysiologic study using one or two tripolar, quadripolar 
or hexapolar electrode catheters introduced into one femoral 
vein. All patients were premeditated with morphine, 0.1 
mg/kg body weight, and benadryl, 1 mg/kg. Intracavitary 
tracirigs along with scalar leads I, II, and III were recorded on 
a multichannel oscilloscope recorder (Electronics for Medicine 
VR 12) at a paper speed of 100 mm/s, using a filter setting of 
40 to 500 hertz for intracavitary electrograms. The right 
atrium in all seven patients and the apex of the right ventricle 
in four were stimulated using a programmable stimulator 
(Medtronic 5325). In all seven patients premature atria1 
stimulation during sinus rhythm was performed. The entire 
TABLE I 
Clinlcal Data in 38 Patients with Ventricular Tachycardia 
cardiac cycle was scanned to the point of atria1 refractoriness. 
Atria1 pacing at rates of 120, 150 and 180 beats/min for 30 
seconds was also performed in all seven patients. Finally, in 
four patients, premature v&tricular stimulation during right 
ventricular pacing was performed. The entire cardiac cycle 
was scanned to the point of ventricular refractoriness. Pro- 
cainamide or phenytoin was then given intravenously and 
ventricular stimulation was repeated. 
Results 
Clinical features (Table. I): Cardiovascular ab- 
normalities were present in 21 of the 38 patients. These 
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None 180-260 Syncope Prop 
:: 
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:: ; 2 
None 120 None None 
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None 140 None None 
:f 
M 3 None 170 Dizziness Prop, quin 
10 
: :5 
None 220 Dizziness Prop 
37 14 days 
4’ 
None 150-170 None Prop 
38 8 M None 120 None None 
Al = aortic insufficiency: AS = aortic stenosis; AVR = aortic valve replacement; CHF = congestive heart failure; Dig = digoxin; MVP = mitral 
valve prolapse; MVR = mitral valve replacement; Palp = palpitations; Phen = phenytoin; Postop = postoperative: Proc = procainamide; PS = 
pulmonary stenosis; Quin = quinidine; s/p = status post; TAPVR = total anomalous pulmonary venous return; ToF = tetralogy of Fallot; V = ventricle; 
VSD = ventricular septal defect; VT = ventricular tachycardia. 
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TABLE II 
Symptoms in Patients With Ventricular Tachycardia 
Heart Disease No Heart Disease 
Symptoms 
Death 0 0 
Cardiac arrest 5 0 
Syncope 5 3 
Dizziness and/or 7 3 
lightheadedness 
Total patients 
with symptoms 17 of 21 6of 16 
(p <O.Ol) 
tetralogy of Fallot in four, myocarditis in three, pro- 
longed Q-T syndrome in three and other congenital 
heart lesions in six. Seventeen patients had no known 
heart disease. There were no significant differences 
between the patients with and without heart disease 
with regard to age at diagnosis of ventricular tachy- 
cardia (0.2 to 19 years [mean f standard error of the 
mean 9.8 f 2.51 versus 2 days to 16 years [mean 11.5 f 
3.2 years]); and duration of follow-up (0.4 to 10 years 
[mean 3.9 f 2.71 versus 0.5 to 12 years [mean 4.9 f 2.61). 
There were three deaths in the patients with heart 
disease, all secondary to the underlying heart disease 
(severe congestive heart failure in Patients 6 and 20 and 
aortic stenosis [during aortic valve replacement] in 
Patient 17); there were no deaths in the patients without 
heart disease. 
Cardiac catheterization findings: Cardiac cathe- 
terization was performed in 24 of the 38 patients (19 of 
the 21 patients with and 5 of the 17 patients without 
underlying heart disease). Left ventricular asynergy was 
observed in all five patients with mitral valve prolapse. 
Left ventricular dysfunction, as documented by an 
ejection fraction of less than 50 percent, was present in 
all three patients with myocarditis. No abnormalities 
of left ventricular function or contraction pattern were 
noted in the five patients without heart disease. Selec- 
tive right and left coronary angiography ruled out the 
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FIGURE 1. Graph demonstrating the relation between symptoms and 
the rate of ventricular tachycardia (VT) at rest. The closed circles 
represent the patients (Pts) with heart disease (HD); the squares rep- 
resent the patients without known heart disease (NHD); the horizontal 
rules indicate mean values f standard error of the mean. 
Symptoms due to ventricular tachycardia (Table 
II): Symptoms directly referable to the ventricular 
tachycardia were observed in 17 of the 21 children with 
and in 6 of the 17 children without heart disease (p 
<O.Ol, chi-square = 6.7). The patients with underlying 
heart disease not only had more symptoms, but also 
their symptoms were more severe. Cardiac arrest re- 
quiring cardiopulmonary resuscitation and cardiover- 
sion occurred in 5 of the 17 symptomatic children with 
heart disease and in none of the children without heart 
disease. Three of the patients without heart disease 
(Patients 28,31 and 32) had been followed up for 5,6 
and 8 years, respectively, with asymptomatic ventricular 
tachycardia before a syncopal episode developed. 
Like the presence of heart disease, the rate of ven- 
tricular tachycardia appears to be related to symptoms 
(Fig. 1). Symptomatic patients had a significantly faster 
rate of ventricular tachycardia than that of the 
asymptomatic patients (220 f 28 versus 134 f 12 
beats/min) (p <O.Ol). All symptomatic patients, 
whether or not they had underlying heart disease, had 
rates of ventricular tachycardia greater than 150 
beats/min, whereas only one asymptomatic patient 
(Patient 37, a 14 day old infant) had such a rate (Fig. 2). 
pt#4 VT RATE 215 RXT!M’rin 
pt#29 L-33c4 VT RATE 122 EEAlSImh 
pt#n VT RATE 160 BEAT%nin 
FIGURE 2. Representative electrocardiographic strips obtained from 
three patients (pt) with ventricular tachycardia. Patient 4 has predom- 
inantly normal sinus rhythm with a burst of ventricular tachycardia (VT) 
at a heart rate of 215 beats/min. Patient 29 has a Holter monitor strip 
that demonstrates ventricular tachycardia at 122/min. This patient has 
no known heart disease as documented by cardiac catheterization 
studies including ventricuiar and crxonary angiography as well as normal 
M mode and two dimensional echocardiograms. Patient 37 is the 14 
day old infant with ventricular tachycardia at a rate of 160lmin. This strip 
is from a Holter monitor recording with twice normal standardiza- 
tion. 
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TABLE III 
Symptoms Versus Results of Exercise Testing in 21 
Children With Ventricular Tachycardia 
Symptomatic Asymptomatic 
(n=ll) p (n = 10) 
No change in PVCs 
lncraase in PVCs : <O.Ol ; 
Couplets 
VT : 
Decreased or abolished 0 <O.Ol 9 
PVCS 
PVCs = premature ventricular complexes. 
The rate of the ventricular tachycardia varied in the 
same child with time; however, no symptomatic patient 
had a documented ventricular tachycardia rate of less 
than 150 beats/min, and only three of the asymptomatic 
patients (Patients 8,21 and 37) had a rate greater than 
or equal to 150 beats/min. 
Exercise testing: Graded treadmill exercise testing 
was performed in 21 of the 38 children with ventricular 
tachycardia (Table III). Exercise testing increased the 
degree of ventricular arrhythmia in 8 of 11 symptomatic 
patients. Ventricular tachycardia was Precipitated by 
exercise in six of these children (Fig. ‘3 and 4). Five 
children experienced symptoms with their exercise- 
induced ventricular tachycardia (dizziness in Patients 
3,4,28 and 311 and sustained ventricula? tachycardia 
requiring cardioversion in Patient 18 (Fig. 4). Patients 
32 and 36 exhibited ventricular couplets during tread- 
mill exercise performed 0.5 to 2 years before the devel- 
opment of symptomatic ventricular tachycardia. In 
FIGURE 3. Patient 31. Exercise 
stress test in a patient with no 
known heart disease. Ventricular 
tachycardii (VT) was provoked at 7 
minutes of exercise and the rate of 
ventricular tachycardia increased 
from 185 to 250 beats/min at 8 
minutes of exercise. 
contrast to results in the symptomatic patients, tread- 
mill exercise testing decreased (5 patients) or abolished 
(4 patients) ventricular arrhythmia in 9 of 10 asymp- 
tomatic patients. Four of the asymptomatic patients 
(Patients 24 to 26 and 34) had short bursts of ventricular 
tachycardia at rest that were suppressed by exercise. 
Electrophysiologic data: Seven patients (Patients 
1, 4, 7 and 12 to 15) underwent an electrophysiologic 
study. Patient 7 had frequent spontaneous bursts of 
ventricular tachycardia that could be suppressed by 
atria1 or ventricular pacing at a rate greater than 135 
beats/min. Programmed stimulation of the atrium 
failed to initiate ventricular tachycardia in all seven 
patients. 
Single or double spontaneous ventricular responses 
occurred after premature ventricular stimulation during 
ventricular pacing in Cases 12 to 15. In three of these 
patients intravenous administration of either procain- 
amide (Patients 13 and 15) or phenytoin (Patient 14) 
abolished the repetitive ventricular response. 
Antiarrhythmic therapy: This therapy was ini- 
tiated in 28 of the 38 children with ventricular tachy- 
cardia. Effectiveness of therapy was assessed with the 
combined use of 24 hour Holter monitoring and graded 
treadmill exercise testing in 14 children, and with 
multiple 24 hour Holter monitoring alone in 14. In 4 
(Patients 1, 3, 12 and 32) of the 14 children who un- 
derwent both exercise testing and Holter monitoring, 
the tachycardia appeared to be abolished on 24 hour 
Holter monitoring, but treadmill exercise still provoked 
the tachycardia. 
The results of the last 24 hour Holter and last 
treadmill test (when available) in 28 children on an- 





VT = 2!iO BEATS/min 
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Therapy eliminated symptoms and abolished ventric- 
ular tachycardia in all 23 symptomatic patients, but 
failed to abolish tachycardia in 2 of 5 treated asymp- 
tomatic patients (Cases 7 and 24). Only a few compli- 
cations of antiarrhythmic therapy were noted in the 28 
children; quinidine caused fever and diarrhea in patient 
28 and phenytoin caused gingival hypertrophy in Pa- 
tients 9 and 12. 
Antiarrhythmic agents: A wide spectrum of anti- 
arrhythmic agents have been used in our children with 
ventricular tachycardia. including propranolol, quini- 
dine, phenytoin, digitalis and proeainamide. Certain 
drugs were more effective in specific groups of children. 
Propranolol alone eliminated symptoms and ventricular 
tachycardia in three children with mitral valve prolapse. 
However, in Patients 1 and 3, propranolol abolished 
ventricular tachycardia on 24 hour Holter monitoring, 
but exercise, still provoked the tachycardia. Only after 
the addition of quinidine was ventricular tachycardia 
effectively controlled. In the three patients with a pro- 
longed Q-T syndrome, the combination of propranolol 
and phenytoin effectively controlled symptoms and 
abolished ventricular tachycardia. 
Phenytoin appeared to be the antiarrhythmic agent 
of choice in our patients after repair of tetralogy of 
Fallot. Phenytoin alone abolished ventricular tachy- 
cardia and symptoms in Patients 13 to 15. In Patient 12, 
ventricular tachycardia was not completely eliminated 
by quinidine and digitalis, but was abolished with the 
addition of phenytoin. 
Discussion 
Prognosis: Limited information is available on the 
long-term follow-up and management of children and 
adolescents with ventricular tachycardia. It is clear from 
our study, as well as from previous reports,l-g that 
ventricular tachycardia may occur in children with or 
without evidence of heart disease. In our patients, three 
factors appeared to be helpful in predicting the prog- 
nosis of children with ventricular tachycardia: (1) the 
presence of underlying cardiac disease, (2) the rate of 
tachycardia, and (3) the response of the child to graded 
treadmill exercise. 
Role of underlying heart disease: Symptomatic 
ventricular tachycardia occurred more frequently in 
children with than in children without underlying heart 
disease. In addition, the children with heart disease not 
only had more symptoms, but also had more severe 
symptoms. Mitral valve prolapse, myocarditis and re- 
paired tetralogy of Fallot were the conditions most 
frequently associated with ventricular tachycardia. 
Pedersen et al.* also found that mitral valve prolapse 
was the most frequent underlying condition associated 
with ventricular tachycardia. Swartz et al.11 reported 
that ventricular tachycardia occurred in 37 of 589 adult 
patients with mitral valve prolapse (6.3 percent). Al- 
though the origin of arrhythmias in patients with mitral 
valve prolapse is unknown, Gooch et a1.12 suggested that 
left ventricular asynergy may be partly responsible for 
the arrhythmias observed in patients with mitral valve 
prolapse. All five of our children with mitral valve pro- 
6 MINUTES of EXERCISE 
VT = 280 BEATS/min 
f’T#18 
6 SECONDS----------- 
FIGURE 4. Patient 18 (aortic insufficiency). A continuous lead II rhythm 
strip is displayed. Ventricular flutter at a rate of 280 beats/min devel- 
oped after 6 minutes of treadmill exercise testing. During the tachy- 
cardia, the patient experienced hypotension, angina and chest pain. 
Cardioversion was required to terminate the ventricular tachycardia 
(VT). 
lapse and ventricular tachycardia had teft ventricmar 
asynergy (“ballerina foot pattern,“is anterior convex 
bulging during late systole and early diastole). 
Role of rate of tachycardia: Our data also suggested 
that the rate of ventricular tachycardia affects the na- 
ture of the patient’s symptoms. All of our symptomatic 
patients, with or without heart disease, had ventricular 
tachycardia at rates greater than 150 beats/min. Three 
patients (Cases 28,31 and 32) had asymptomatic ven- 
tricular tachycardia for 5 to 8 years at a rate of greater 
than 150 beats/min before a syncopal episode devel- 
oped. Other+l7 have also reported the benign nature 
of slow ventricular tachycardia and have chosen to call 
this condition accelerated ventricular rhythm rather 
than ventricular tachycardia.14-I7 Pedersen et al.2 re- 
ported that the rate of ventricular tachycardia influ- 
ences the nature of the patient’s symptoms but believed 
that a slower rate did not necessarily assure a good 
prognosis since two of their three patients who died had 
ventricular tachycardia with a rate of 154 and 158 
beatslmin, respectively. 
Prognostic value of exercise testing: Finally, we 
observed that the response of patients to graded stress 
exercise testing was useful in predicting the prognosis 
in children with ventricular tachycardia. In the symp- 
tomatic patient, exercise usually increased the degree 
of ventricular arrhythmia; in the asymptomatic patient, 
exercise abolished the arrhythmia or decreased its de- 
gree. Ryan et al.ls also demonstrated that exercise 
testing was useful in evaluating ventricular arrhythmia 
in adults with coronary artery disease. In contrast, 
Pedersen et a1.2 did not find the results of stress testing 
prognostically helpful in their patients with ventricular 
tachycardia, but did observe that exercise suppressed 
the ventricular tachycardia in patients with slow ven- 
tricular tachycardia (rates less than 150 beats/min). The 
poor prognostic value of exercise testing in the study of 
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TABLE Iv 
Results of Antiarrhythmic Therapy in 28 Children With Ventricular Tachycardia 
Case 
Symptoms Agent and 
Pre Dose 
Therapy tmg) 
Drug Therapy Lown Classification 
Ventricular Ectopy 
Plasma Years Symptoms 
Drug Side on Last Last Post 
Level Effects Medication Holter Treadmill Therapy 














13 Palp, dizziness 
14 Palp, dizziness 
15 Palp, dizziness 
17 Dizziness, angina 
18 Angina, dizziness, 
palp 




Prop, 20 qid 
Prop, 20 qid 
Quin, 200 qid 
Prop, 20 qid 
Prop, 40 qid 
Prop, 40 qid 
@in, 300 qid 
Prop, 20 qid 
Prop, 20 qid 
Quit-r, 50 qid 
Dig, 0.05 bid 
Quin, 330 bid 
Phen, 30 tid 
Dig, 0.1 bid 
Prop, 20 qid 
Prop, 20 qid 
Phen, 50 tid 
Prop, 15 qid 
Phen, 40 bid 
Prop, 20 qid 
Dig 0.125 bid 
Quin, 200 qid 
Dig, 0.125 bid 
Quin, 200 qid 
Phen, 100 tid 
Phen, 300 tid 
Phen, 100 tid 
Phen. 100 tid 
Quin, 150 qid 
Dig, 0.125 bid 
Quin 200 qid 
Proc, 375 qid 
Dig, 0.125 qid 
Quin, 200 qid 
Dig, 0.06 bid 
Quin, 50 qid 
Dig, 0.03 bid 
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Patients With No Heart Disease 
24 None Prop, 20 qid 49 ngJml None 
Quin, 100 qid 3.8 PgJml None 
3 IVB 0 None 
27 None Prop, 20 qid None 5 II 0 None 
28 Syncope Prop, 40 qid 42 ngJml None 2 II I None 
30 Dizziness, palp Prop, 20 qid . None 
Quin, 200 qid None 2 
III I None . 
31 Syncope Prop, 40 qid 44 ngJml None 3 II I None 
32 Syncope Prop, 40 qid . None 2 wk Ill IVB 
Prop, 40 qid None 
Quin, 200 qid None 
4 Ill II None 
35 Dizziness Prop, 30 qid 35 ngJml None 
Quin, 200 qid 3.7 PgJml None 3 II . None 
36 Dizziness Prop,lOqid . . . None 7 II I None 
37 None Prop, 1.75 qid . None 0.5 II None 
I = less than 1 premature ventricular complex/min; II = 1 premature ventricular complexJmin: Ill = multifocal premature ventricular complexes; 
IVA = couplets: IVB = ventricular tachycardia; Ging hyp = gingival hypertrophy; other abbreviations as in Table I. 
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Pedersen et al.” may relate to both the small overall 
number of patients and the very small number of 
asymptomatic patients in their study. 
Effect of antiarrhythmic therapy: The majority 
of our children, with or without heart disease, are on 
some form of antiarrhythmic therapy. In our symp- 
tomatic children, antiarrhythmic therapy was effective 
in abolishing ventricular tachycardia, reducing ven- 
tricular arrhythmia and eliminating symptoms. How- 
ever, in the asymptomatic child, arrhythmia control 
appeared to be less effective. Although no double blind 
protocol was used to determine the best antiarrhythmic 
agent for treating children with ventricular tachycardia, 
certain drugs appear to be most effective in specific 
groups of children (propranolol in mitral valve prolapse, 
propranolol and phenytoin in prolonged Q-T syndrome 
and phenytoin in postoperative tetralogy of Fallot’“). 
We also found that the combined use of both 24 hour 
Holter monitoring and repeated graded treadmill ex- 










uating drug effectiveness. Ryan et al.‘s also reported 
that 24 hour Holter monitoring and graded treadmill 
exercise testing were complementary methods that di- 
vulged different information regarding the electro- 
physiologic state of the myocardium. More recently, we 
have also used electrophysiologic studies to evaluate 
drug efficacy. 
Clinical implications: Our dat.a suggest that the 
presence of underlying cardiac disease, the rate of the 
ventricular tachycardia and the results of graded 
treadmill exercise testing are useful in predicting the 
prognosis of children with ventricular tachycardia. Al- 
though the long-term effects of chronic antiarrhythmic 
therapy in the growing child are not known, we cur- 
rently recommend antiarrhythmic therapy for all 
symptomatic patients with ventricular tachycardia and 
for those asymptomatic patients with both ventricular 
tachycardia rates greater than 150 beatslmin and a 
significant increase in ventricular arrhythmia with 
stress testing. 
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